	Capitaux D'Emprunt		Date
Agios Pharmaceuticals	USD 1.06M	0	2022-09
Alnylam Pharmaceuticals	USD 2.48B	1.44B	2025-12
Amgen	USD 50B	2.43B	2025-12
Biogen	USD 6.29B	1.4M	2025-09
BioMarin Pharmaceutical	USD 597.18M	513K	2025-12
Daiichi Sankyo	JPY 300.15B	199.41B	2025-12
Esperion Therapeutics	USD 262.48M	235.95M	2024-06
Gilead Sciences	USD 22.14B	5M	2025-09
Glaxosmithkline	GBP 20.02B	4.72B	2025-09
Incyte	USD 30.2M	5.17M	2025-12
MacroGenics	USD 70.26M	4K	2025-09
Moderna	USD 610M	584M	2025-12
Novartis	USD 24.24B	174M	2025-09
Pfizer	USD 57.41B	93M	2025-09
PTC Therapeutics	USD 2.03B	193.22M	2025-12
Puma Biotechnology	USD 10.87M	222K	2025-06
Regeneron Pharmaceuticals	USD 2.71B	720.4M	2025-12
Roche Holding	CHF 27.43B	966M	2025-12
Sangamo BioSciences	USD 0	0	2022-06
Sarepta Therapeutics	USD 828.97M	206.17M	2025-12
Takeda	JPY 4.27T	81.29B	2025-12
TG Therapeutics	USD 245.64M	305K	2025-12
Ultragenyx Pharmaceutical	USD 763.74M	19.02M	2025-09
Vanda Pharmaceuticals	USD 3.15M	3.15M	2024-12
Vertex Pharmaceuticals	USD 111.4M	1.4M	2025-03

Puma Biotechnology Capitaux D'Emprunt - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2026.